Mr. William U. Parfet is NonExecutive Independent Chairman of the Board of Stryker Corporationration, since February 8, 2012. He has served as Chairman and Chief Executive Officer of MPI Research, Inc., a drug safety and pharmaceutical development company, since 1999. He is also a director of Monsanto Company, a provider of agricultural products that improve farm productivity, and Taubman Centers, Inc., a real estate development company.
Non-Executive Chairman and Member of Governance and Nominating Committee
Age: 65 Chairman Since 2012
The company has Return on Asset of 8.43 % which means that on every $100 spent on asset it made $8.43 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.2 % implying that it generated $15.2 on every 100 dollars invested.
The company has 2.77 B in debt with debt to equity (D/E) ratio of 0.33 which is OK given its current industry classification. Stryker Corporation has Current Ratio of 4.57 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Entity SummaryStryker Corporationration, a medical technology company, offer reconstructive, medical and surgical, and neurotechnology and spine solutions for doctors, hospitals, and other healthcare facilities. Stryker Corporation [SYK] is traded on New York Stock Exchange in USA. It is located in Kalamazoo, MI and employs 22,010 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| SYK NYSE
Stryker Corporation has less than 12.5 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Stryker price boundaries
Promote Stryker and William Parfet